收费全文 | 14012篇 |
免费 | 1240篇 |
国内免费 | 22篇 |
耳鼻咽喉 | 193篇 |
儿科学 | 413篇 |
妇产科学 | 326篇 |
基础医学 | 1870篇 |
口腔科学 | 193篇 |
临床医学 | 1815篇 |
内科学 | 2658篇 |
皮肤病学 | 203篇 |
神经病学 | 1244篇 |
特种医学 | 401篇 |
外科学 | 1817篇 |
综合类 | 181篇 |
一般理论 | 11篇 |
预防医学 | 1858篇 |
眼科学 | 342篇 |
药学 | 719篇 |
中国医学 | 25篇 |
肿瘤学 | 1005篇 |
2023年 | 167篇 |
2022年 | 290篇 |
2021年 | 688篇 |
2020年 | 336篇 |
2019年 | 559篇 |
2018年 | 544篇 |
2017年 | 405篇 |
2016年 | 411篇 |
2015年 | 432篇 |
2014年 | 602篇 |
2013年 | 771篇 |
2012年 | 1122篇 |
2011年 | 1058篇 |
2010年 | 502篇 |
2009年 | 472篇 |
2008年 | 716篇 |
2007年 | 711篇 |
2006年 | 645篇 |
2005年 | 614篇 |
2004年 | 570篇 |
2003年 | 503篇 |
2002年 | 417篇 |
2001年 | 180篇 |
2000年 | 151篇 |
1999年 | 154篇 |
1998年 | 103篇 |
1997年 | 73篇 |
1996年 | 72篇 |
1995年 | 53篇 |
1994年 | 62篇 |
1993年 | 58篇 |
1992年 | 102篇 |
1991年 | 101篇 |
1990年 | 122篇 |
1989年 | 132篇 |
1988年 | 91篇 |
1987年 | 100篇 |
1986年 | 91篇 |
1985年 | 83篇 |
1984年 | 58篇 |
1983年 | 66篇 |
1979年 | 45篇 |
1978年 | 45篇 |
1977年 | 53篇 |
1976年 | 43篇 |
1975年 | 47篇 |
1974年 | 55篇 |
1973年 | 63篇 |
1972年 | 43篇 |
1970年 | 48篇 |
Background
Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.Objectives
To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.Methods
Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.Results
Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.Conclusions
These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study. 相似文献Methods: [11C]WAY100635, [18F]altanserin and positron emission tomography were used to compare 5-HT1A and 5-HT2A binding in MDD patients divided into eight past suicide attempters (>4yrs prior to scanning) and eight lifetime non-attempters, and both groups were compared to eight healthy volunteers.
Results: The two receptor types differed in binding pattern across brain regions from each other, but there were no differences in binding between healthy volunteers and the two depressed groups or between depressed suicide attempters and non-attempters. No effects of depression severity or lifetime aggression were observed for either receptor.
Conclusion: Limitations of this study include small sample size and absence of high lethality suicide attempts in the depressed attempter group. No trait-like binding correlations with past suicide attempt or current depression were observed. Given the heterogeneity of nonfatal suicidal behavior, a larger sample study emphasizing higher lethality suicide attempts may find the serotonin biological phenotype seen in suicide decedents. 相似文献